冠状动脉钙化积分在慢性阻塞性肺疾病中的应用价值被引量：3

下载PDF

导出

摘要慢性阻塞性肺疾病(慢阻肺),作为呼吸系统常见病位居全球死因谱第4位[1],死亡率有逐年上升趋势,预计2020年将升至第3位[2]。心血管疾病是慢阻肺的常见合并症,是慢阻肺除其自身疾病所致死亡的第二大死亡原因[3]。动脉粥样硬化是心血管疾病的主要病因[3]。早期识别并治疗慢阻肺合并冠状动脉粥样硬化是必要的。冠状动脉钙化(coronary artery calcification,CAC)是冠状动脉粥样硬化的特征。Agatston等[4]自1990年引入的Agatston积分、半定量地评估CAC,至今仍是最常用的计算冠状动脉钙化积分(Coronary artery calcium score,CACS)的方法,可重复性高。CACS的高低与冠状动脉粥样硬化负荷相关。本文就CACS在慢阻肺患者中的应用价值做一综述。

作者马丽君邓毅书

机构地区大理大学临床医学院云南省第二人民医院呼吸科

出处《临床肺科杂志》 2018年第5期942-945,共4页 Journal of Clinical Pulmonary Medicine

关键词冠状动脉钙化积分慢性阻塞性肺疾病冠状动脉粥样硬化 ARTERY 心血管疾病慢阻肺呼吸系统死亡原因

分类号 R563.9 [医药卫生—呼吸系统]

引文网络
相关文献

参考文献2

1李红,吕志强,梁瑞韵.慢性阻塞性肺疾病合并心血管疾病的研究进展[J].临床肺科杂志,2017,22(4):729-734. 被引量：26
2LIANG Bin-miao,XU Zhi-bo,YI Qun,OU Xue-mei,FENG Yu-lin.Association of chronic obstructive pulmonary disease with coronary artery disease[J].Chinese Medical Journal,2013(17):3205-3208. 被引量：14

二级参考文献24

1Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 2003; 107: 363-369.
2Leschka S, Alkadhi H, Plass A, Desbiolles L, Grunenfelder J, Marincek B, et al. Accuracy of MSCT coronary angiography with 64-slice technology: first experience. Eur Heart J 2005; 26: 1482-1487.
3Tan KT, Reed D, Howe J, Challenor V, Gibson M, McGann G. CT vs. conventional angiography in un selected patients with suspected coronary heart disease. Int J Cardiol 2007; 121: 125- 126.
4Rabe KF, Hurd S, Anzueto A, Barnes P J, Buist SA, Calverley P, et al. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007; 176: 532- 555.
5Schunemann HJ, Dom J, Grant BJ, Winkelstein W Jr, Trevisan M. Pulmonary function is a long-term predictor of mortality in the general population: 29-year follow-up of the Buffalo Health Study. Chest 2000; 118: 656-664.
6Engstrom G, Lind P, Hedblad B, Wollmer P, Stavenow L, Janzon L, et al. Lung function and cardiovascular risk: relationship with inflammation-sensitive plasma proteins. Circulation 2002; 106: 2555-2560.
7Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J 2005; 26: 319-338.
8Zheng J, Zhong N. Normative values for pulmonary function testing in Chinese adults. Chin Med J 2002; 115: 50-54.
9Nishiyama K, Morimoto T, Furukawa Y, Nakagawa Y, Ehara N, Taniguchi R, et al. Chronic obstructive pulmonary disease-an independent risk factor for long-term cardiac and cardiovascular mortality in patients with ischemic heart disease. Int J Cardiol 2010; 143: 178-183.
10Selvaraj CL, Gurm HS, Gupta R, Ellis SG, Bhatt DL. Chronic obstructive pulmonary disease as a predictor of mortality in patients undergoing percutaneous coronary intervention. Am J Cardio12005; 96: 756-759.